Showing results (311-320 of 352) with videos related to

Sort By:
Pageof 36
Molecular Pharmaceutics|June 1, 2016
Contribution of Antibody Hydrodynamic Size to Vitreal Clearance Revealed through Rabbit Studies Using a Species-Matched FabWhitney Shatz, Philip E Hass, Mary Mathieu, et al.
Ebiomedicine|July 25, 2020
Single oral dose for HIV pre or post-exposure prophylaxis: user desirability and biological efficacy in macaquesIvana Massud, Susan Ruone, Maria Zlotorzynska, et al.
African Journal of AIDS Research : AJAR|February 26, 2021
Motivating people living with HIV to initiate antiretroviral treatment outside national guidelines in three clinics in the HPTN 071 (PopART) trial, South AfricaConstance Mubekapi-Musadaidzwa, Dillon Wademan, Neshaan Peton, et al.
The Lancet. Respiratory Medicine|December 5, 2021
Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trialZelalem Temesgen, Charles D Burger, Jason Baker, et al.
Blood|July 15, 2006
Synthetic anti-BR3 antibodies that mimic BAFF binding and target both human and murine B cellsChingwei V Lee, Sarah G Hymowitz, Heidi J Wallweber, et al.
Regulatory Toxicology and Pharmacology : RTP|April 1, 2014
Implications of retinal effects observed in chronic toxicity studies on the clinical development of a CNS-active drug candidateG Eichenbaum, J Zhou, M F Kelley, et al.
Pageof 36